Drug Profile
Research programme : bio-orthogonal linker therapeutics - BlinkBio
Latest Information Update: 28 Jan 2019
Price :
$50
*
At a glance
- Originator BlinkBio
- Class
- Mechanism of Action P53 gene modulators; Protein-protein interaction inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Infections